By Kate Snyder A global biotech company based in Switzerland that was in talks to lease space at the Atrium in Emeryville has...
ByThe RegistryJune 21, 2023By Vladimir Bosanac A year after it announced a major expansion and signed a 10-year lease, the six-year-old InterVenn Biosciences is pulling out...
ByThe RegistryJune 16, 2023By Catherine Sweeney InterVenn Biosciences is expanding its reach across South San Francisco. The company, which focuses its work on glycoprotein analysis, has...
ByThe RegistryMay 13, 2022By Sharon Simonson A dedicated cadre of project proponents and building contractors gathered Jan. 10 in Mountain View for the topping out ceremony...
ByThe RegistryJanuary 11, 2013
Signup for news and special announcements!
You have successfully joined our subscriber list.